Neal Masia, PhD

Articles by Neal Masia, PhD

Panel of health care professionals -- Image credit: Africa Studio | stock.adobe.com

Decoding Most Favored Nation: Expert Insights on the Impacts to Patients, Pharma, and Innovation

ByBrian Corvino,Neal Masia, PhD,Ali Pashazadeh,George Van Antwerp, MBA,Ned Milenkovich, PharmD, JD,Gillian McGovern, Editor

September 12th 2025

A panel of 4 experts discussed the most favored nation (MFN) initiative and its impacts on research and development, market and payer distributions, and pharmacists and patients.

Latest Updated Articles

Decoding Most Favored Nation: Expert Insights on the Impacts to Patients, Pharma, and Innovation
September 12th 2025

Neal Masia, PhD

Articles by Neal Masia, PhD

Decoding Most Favored Nation: Expert Insights on the Impacts to Patients, Pharma, and Innovation

Latest Updated Articles

Trending on Pharmacy Times

Patients Report Early, Sustained Functional Gains With First-Line Zongertinib in HER2-Mutant NSCLC

Could CAR T Therapy Become Adjustable After Infusion?